Tolerability and steady-state pharmacokinetics of everolimus in maintenance renal transplant patients

Abstract

These results indicate that up to 5 mg/day everolimus results in a dose-proportional exposure, and is adequately well tolerated in renal transplant recipients receiving cyclosporin and steroids.